Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Po Yueh Chen"'
Autor:
Po-Yueh Chen, Tzu-Ying Chen, Pin-Zhir Chao, Wen-Te Liu, Chyi-Huey Bai, Sheng-Teng Tsao, Yi-Chih Lin
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0303980 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0252844.].
Externí odkaz:
https://doaj.org/article/05447a4cd5d34ad99e1ff1eb980e2a03
Autor:
Cheng-Hao Tseng, Li-Chun Chang, Jia-Ling Wu, Chi-Yang Chang, Chi-Yi Chen, Peng-Jen Chen, Chia-Tung Shun, Wen-Feng Hsu, Yen-Nien Chen, Chieh-Chang Chen, Tien-Yu Huang, Chia-Hung Tu, Mei-Jyh Chen, Chu-Kuang Chou, Ching-Tai Lee, Po-Yueh Chen, Jaw-Town Lin, Ming-Shiang Wu, Han-Mo Chiu
Publikováno v:
American Journal of Gastroenterology (Lippincott Williams & Wilkins); Nov2024, Vol. 119 Issue 11, p2233-2240, 8p
Autor:
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Chun-Jen Liu, Ching-Chu Lo, Ke-Jhang Huang, Jyh-Jou Chen, Kuo-Chih Tseng, Chi-Yang Chang, Cheng-Yuan Peng, Yu-Lueng Shih, Chia-Sheng Huang, Wei-Yu Kao, Sheng-Shun Yang, Ming-Chang Tsai, Jo-Hsuan Wu, Po-Yueh Chen, Pei-Yuan Su, Jow-Jyh Hwang, Yu-Jen Fang, Pei-Lun Lee, Chi-Wei Tseng, Fu-Jen Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chun-Chao Chang, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 4, Pp 575-588 (2021)
Background/Aims Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited. Methods We included 107 patients with Child-P
Externí odkaz:
https://doaj.org/article/4ef4e404f00c418597db8898e8c2d587
Autor:
Chen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, Po-Yueh Chen, Chi-Jen Chu, Keng-Hsin Lan, I-Cheng Lee, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 385-395 (2021)
Background/purpose: The treatment of chronic hepatitis C (CHC) has evolved from interferon (IFN)-based therapy to direct acting antivirals (DAAs). The effect of antiviral treatment on outcome of hepatocellular carcinoma (HCC) patients with CHC has no
Externí odkaz:
https://doaj.org/article/b971eb74441e463a96ffc6d7685c3c57
Publikováno v:
Journal of Functional Biomaterials, Vol 14, Iss 7, p 337 (2023)
This retrospective study compared the effectiveness of different materials used in Uvulopalatopharyngoplasty (UPPP) for snoring or obstructive sleep apnea treatment, focusing on the impact on bleeding control, pain control, and healing ability. The s
Externí odkaz:
https://doaj.org/article/cf714537b27b43c68b00ba9fc7680a10
Autor:
Yi-Chih Lin, Chun-Tien Chen, Pin-Zhir Chao, Po-Yueh Chen, Wen-Te Liu, Sheng-Teng Tsao, Sheng-Feng Lin, Chyi-Huey Bai
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
PurposeTo determine whether treatment with uvulopalatopharyngoplasty (UPPP) or continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) prevents hypertension, compared to those not receiving any treatment.MethodsA ret
Externí odkaz:
https://doaj.org/article/5b15d9125f314af18a9e223b288e3b4a
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 11, Pp 2042-2043 (2021)
Externí odkaz:
https://doaj.org/article/6eb09e3f9aab43a98b56151fafb9a278
Autor:
Po-Yueh Chen, Tzu-Ying Chen, Pin-Zhir Chao, Wen-Te Liu, Chyi-Huey Bai, Sheng-Teng Tsao, Yi-Chih Lin
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252844 (2021)
BackgroundIn recent population-based case-control studies, sleep apnea was significantly associated with a higher incidence (hazard ratio, 1.71) of vertigo and the risk of tinnitus was found to increase 1.36 times in patients with sleep apnea. The po
Externí odkaz:
https://doaj.org/article/765cdb48b7d54e87b86595a16e429161
Autor:
Li-Jen Chang, Han-Cheng Chang, Po-Yueh Chen, Chi-Yi Chen, Kun-Feng Tsai, Koh-Kok Yean, Hsin-Yi Yang, Tsung-Hsien Chen, Pao-Ta Yu, Chu-Kuang Chou, Sheng-Hsuan Chen
Publikováno v:
Medicina, Vol 58, Iss 4, p 521 (2022)
Background and Objectives: Direct-acting antiviral agents (DAA) are a safe and highly effective treatment for hepatitis C virus (HCV) infection. However, the uptake of DAA treatment remains a challenge. This study aims to examine the reasons for DAA
Externí odkaz:
https://doaj.org/article/1fdde75668444f8b83bca223f7629e80
Autor:
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, Chi-Yi Chen, Ching-Chu Lo, Kuo-Chih Tseng, Pei-Yuan Su, Wei-Yu Kao, Ming-Chang Tsai, Hung-Da Tung, Hao-Tsai Cheng, Fu-Jen Lee, Chia-Sheng Huang, Ke-Jhang Huang, Yu-Lueng Shih, Sheng-Shun Yang, Jo-Hsuan Wu, Hsueh-Chou Lai, Yu-Jen Fang, Po-Yueh Chen, Jow-Jyh Hwang, Chi-Wei Tseng, Wei-Wen Su, Chun-Chao Chang, Pei-Lun Lee, Jyh-Jou Chen, Chi-Yang Chang, Tsai‐Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Publikováno v:
Hepatology International. 17:291-302
Background Real-world data are scarce about the effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for retreating East Asian patients with hepatitis C virus (HCV) infection who previously received NS5A direct-acting antivir